GABRD Accelerates Tumour Progression via Regulating CCND1 Signalling Pathway in Gastric Cancer
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Weibing Leng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Cancer Center, Sichuan University West China Hospital, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Cyclin D1, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Xisike Clinical Oncology Research Foundation, Beijing Science and Technology Innovation Medical Development Foundation, Natural Science Foundation General Project of Shandong Province.
Abstract (Originalsprache)
Neurotransmitters and their receptors were reported to be involved in tumour initiation and progression. However, little is known about their roles in gastric cancer (GC). Here, we first identified gamma‐aminobutyric acid type A receptor subunit delta (GABRD) as a novel oncogene in GC. GABRD was preferentially upregulated in GC tissues compared with adjacent normal tissues. High GABRD expression was significantly associated with poor survival prognosis. Knockdown of GABRD could markedly induce cell apoptosis and cell cycle arrest while repressing proliferation and migration in vitro, and suppress tumour growth in vivo. The results of transcriptomic analysis and Ingenuity pathway analysis (IPA) highlighted that cyclin D1(CCND1) was a potential downstream target. Immunohistochemistry results also indicated that CCND1 expression was associated with GABRD in GC. Functional experiments also confirmed that the role of GABRD in regulating proliferation, migration, invasion, and apoptosis was dependent on CCND1. Mechanically, further research confirmed that GABRD knockdown could induce p53‐dependent apoptosis through CCND1, and GABRD upregulated CCDN1 through inhibiting its ubiquitin‐mediated degradation. Overall, these findings uncover a role for the neurotransmitter receptor GABRD in regulating the proliferation and apoptosis of gastric cancer cells. Our present study provides novel insights into the mechanism of tumourigenesis in gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Colorectal Cancer Center, Sichuan University West China Hospital, Chengdu, Sichuan, China.
- Department of Medical Oncology, Sichuan University West China Hospital, Chengdu, Sichuan, China.
- Department of Proctology, Traditional Chinese Medicine Hospital of Longquanyi, Chengdu, Sichuan, China.
- West China School of Medicine, Sichuan University, Chengdu, Sichuan, China.
- Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
ORCID-Profile: Weibing Leng
Förderung
- Beijing Xisike Clinical Oncology Research Foundation
- Beijing Science and Technology Innovation Medical Development Foundation
- Natural Science Foundation General Project of Shandong Province
Zitieren
APA
Leng, W., Ye, J., Wen, Z., Wang, H., Zhu, Z., Song, X., & Liu, K. (2025). GABRD Accelerates Tumour Progression via Regulating CCND1 Signalling Pathway in Gastric Cancer. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70485
Vancouver
Leng W, Ye J, Wen Z, Wang H, Zhu Z, Song X, et al. GABRD Accelerates Tumour Progression via Regulating CCND1 Signalling Pathway in Gastric Cancer. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70485
BibTeX
@article{Leng2025,
author = {Leng, Weibing and Ye, Jun and Wen, Zhenpeng and Wang, Han and Zhu, Zhenyu and Song, Xilin and Liu, Kai},
title = {GABRD Accelerates Tumour Progression via Regulating CCND1 Signalling Pathway in Gastric Cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70485}
}
EUVIMED